Kirby McInerney LLP Announces Investigation Against Encompass Health Corporation (EHC) on Behalf of Investors
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Encompass Health Corporation (“Encompass Health” or the “Company”) (NYSE:EHC). The investigation concerns whether Encompass Health and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
[LEARN MORE ABOUT THE INVESTIGATION]
On July 15, 2025, The New York Times published an article highlighting safety concerns at several of Encompass Health’s rehabilitation hospitals. Specifically, the article revealed that federal data and inspection reports show that Encompass Health’s hospitals have “statistically significantly worse rates of potentially preventable readmissions.” The report further revealed “alarming mistakes” including carbon monoxide poisoning, medication errors, and bed alarm failures leading to fatalities of patients in their care.
On this news, the price of Encompass Health’s shares declined by $12.39, or approximately 10.4%, to close at $107.28 per share on July 15, 2025, thereby injuring investors.
If you purchased or otherwise acquired Encompass securities, have information, or would like to learn more about this investigation, contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or by filling out the form below to discuss your rights or interests with respect to these matters without any cost to you.
Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
